ライフサイエンスコーパス: health expenditure

1 ousehold economic hardship, and catastrophic health expenditure).

2 euro 155 billion (55%), equalling 11% of EU-health expenditure.

3 better care ratings than countries with low health expenditure.

4 diture, and avert 3266 cases of catastrophic health expenditure.

5 atment costs for the countries, and European health expenditure.

6 ith GDP per capita and proportion of current health expenditure.

7 lity is low but increases with high national health expenditure.

8 Ts as a proportion of each country's current health expenditure.

9 usage, income, old-age dependency ratio, and health expenditure.

10 orresponding to an average of 4.6% of global health expenditure.

11 and for which long-term care costs outweigh health expenditure.

12 per capita gross domestic product and total health expenditure.

13 osed global goal with a moderate increase in health expenditure.

14 ed with any statistically significant mental health expenditures.

15 ending, and reducing shares of out-of-pocket health expenditures.

16 g to an imbalance between disease burden and health expenditures.

17 ing the imbalance between disease burden and health expenditures.

18 hospital spending as a proportion of mental health expenditures.

19 blic finance can insure against catastrophic health expenditures.

20 bstantial positive impact by lowering public health expenditures.

21 ization, the first major vascular event, and health expenditures.

22 domestically and externally financed public health expenditures.

23 lation $34,203,445.87 (198,037,951.56 LE) in health expenditures.

24 nancial risk to insurers can reduce budgeted health expenditures.

25 from 1997 to 2005, more rapidly than overall health expenditures.

26 und to protect families against catastrophic health expenditures.

27 treatment with antipsychotic medication and health expenditures.

28 longevity of the elderly without increasing health expenditures.

29 % CI, -10.3 mSv to -8.7 mSv), and lower mean health expenditures (-$10 916; 95% CI, -$16 112 to -$571

30 Out of Jordan's total health expenditure, 19.0% in 1990, 21.1% in 2020, and 25

31 osure, procedure-related adverse events, and health expenditures 2 years after nodule detection.

32 % CI, +5.8 mSv to +7.8 mSv), and higher mean health expenditures ($20 132; 95% CI, +$14 398 to +$25 8

33 ; and change in proportion with catastrophic health expenditure: -7%, P = 0.02).

34 d by 38% from 2000 to 2005; equity of public-health expenditure across states improved; Seguro Popula

35 significantly associated with reductions in health expenditures after adjusting for confounders, esp

36 lion US dollars), the proportion of national health expenditures allocated to CCM decreased by 5.4%.

37 he proportion of hospital costs and national health expenditures allocated to critical care medicine

38 Inequalities also exist in catastrophic health expenditure among households in Nigeria.

39 ts for significant morbidity, mortality, and health expenditures among cancer survivors.

40 12-30, which represents 4-8% of total annual health expenditures among low-income and lower middle-in

41 y gap increase attributable to out-of-pocket health expenditures among the 122 countries in our sampl

42 verall, atopic dermatitis represents a major health expenditure and has been associated with multiple

43 t, place many people at risk of catastrophic health expenditure and pose high opportunity costs for h

44 ionships of common health system inputs (eg, health expenditure and workforces) to the GBD outputs in

45 mance in the short and long term by reducing health expenditures and avoiding productivity losses.

46 strong standardised monitoring of government health expenditures and government spending in other hea

47 t that it only considered gradual changes in health expenditure, and did not account for more severe

48 urce for assessment of longitudinal outcome, health expenditure, and disparities for children with co

49 ions, policy of protection from catastrophic health expenditure, and national treatment guidelines in

50 al multiple sclerosis prevalence, government health expenditure, and proportion of time treated with

51 d with measures of national economic output, health expenditure, and urbanization.

52 ed 13.3% of hospital costs, 4.2% of national health expenditures, and 0.56% of the gross domestic pro

53 ed 13.4% of hospital costs, 4.1% of national health expenditures, and 0.66% of the gross domestic pro

54 imbalance between disease burden and mental health expenditures, and modelled the association betwee

55 spending as a proportion of total government health expenditures, and of psychiatric hospital spendin

56 s (NCDs), efficiency in delivery, control of health expenditures, and public satisfaction.

57 y, health-care service use, and catastrophic health expenditures; and whether these associations vari

58 ical disease indicators, and higher domestic health expenditures are facilitating factors that promot

59 sts contributes to delay in seeking care, as health expenditures are financially catastrophic for fam

60 of people in households whose out-of-pocket health expenditures are large relative to their income o

61 Mental health expenditure as a proportion of government health

62 Malawi should current forecasts of declining health expenditure as a share of GDP materialise, and un

63 t association between efficiency and current health expenditure as a share of gross domestic product,

64 this will result in considerable savings on health expenditure as, not only is raised blood pressure

65 to increase irrespective of yearly growth in health expenditure, assuming current reach, and scope of

66 xorable and unsustainable increase in global health expenditure attributable to diabetes, so disease

67 Although it is imperative that national health expenditure be controlled, ophthalmology has shou

68 levels expected in countries with per capita health expenditure below US$100, and lower than a tenth

69 der health systems financing and patterns of health expenditure beyond the three diseases.

70 pita is not strongly correlated with overall health expenditure, but does correlate strongly with mor

71 methods to disaggregate all publicly funded health expenditure by disease and comorbidities in order

72 answer three research questions: (1) What is health expenditure by disease phase for noncommunicable

73 Increasing health expenditure by just $5 per person per year up to

74 f outpatient and inpatient services in total health expenditure by location and year and estimated un

75 er number of under-5 deaths and catastrophic health expenditure cases in poorer quintiles, but would

76 We found no evidence that health expenditures changed for middle-income surgical p

77 quantify the number of cases of catastrophic health expenditure (CHE) averted by a range of vaccines

78 We analysed catastrophic health expenditure (CHE) in 2020 in five countries with

79 e incidence and determinants of catastrophic health expenditure (CHE) in people with chronic respirat

80 the magnitude of the associated catastrophic health expenditures (CHEs) for selected VPDs in Ethiopia

81 d with 10.8% (7.8 million operations) in low health expenditure countries and 2.7% (5.1 million opera

82 ations) of the total surgical volume in poor health expenditure countries compared with 10.8% (7.8 mi

83 es and 2.7% (5.1 million operations) in high health expenditure countries.

84 polated to 182 countries based on World Bank health expenditure data.

85 prevalence of catastrophic and impoverishing health expenditures, especially for the poor.

86 %-24.7%]) but increased risk of catastrophic health expenditures (expenses alone: 12.4% [95% CI, 11.2

87 th care system in the world, with per capita health expenditures far above those of any other nation.

88 ing a top-down approach based on WHO general health expenditure figures and prevalence data from the

89 lting in financial hardship and catastrophic health expenditure for the most vulnerable.

90 The expected cumulative health expenditures for healthier elderly persons, despi

91 Medicaid and Department of Mental Health expenditures for mental health per treated benefi

92 icantly increased likelihood of catastrophic health expenditure (for the overall population: odds rat

93 er governance, having a higher percentage of health expenditure from the government, infrastructure t

94 every US$1 of DAH to government, government health expenditures from domestic resources were reduced

95 o total health expenditure (THE), government health expenditure (GHE), income status and the burden o

96 cations greatly outpaced inflation, national health expenditure growth, and increases in reimbursemen

97 ries in the highest tertile of out-of-pocket health expenditures had higher odds of elevated choleste

98 Health expenditure has increased substantially since 199

99 US health expenditures have been growing at an unsustainabl

100 ll countries without available data based on health expenditure in 2012 and assessed the proportion o

101 causes of mortality and calculate per capita health expenditure in octogenarians, nonagenarians and c

102 COVID-19 incurred higher health expenditure in rural areas compared to urban area

103 r less than 1 percent of all direct personal health expenditures in the United States.

104 Countries' health expenditures include paying for general medicine,

105 re at particularly high risk of catastrophic health expenditures (including premiums: 81.7% [95% CI,

106 red whether completeness was associated with health expenditure indicators adjusting for surveillance

107 man resources for health, high out-of-pocket health expenditures, inflation in health spending, and b

108 Total national health expenditure is associated with geographical inequ

109 is little systematic assessment of how total health expenditure is distributed across diseases and co

110 ost-effective interventions in Malawi, where health expenditure is low, and should be scaled up in pa

111 ld values expressed as proportion of current health expenditures: low (<0.005%), moderate (0.005% to

112 ransfer amounts, and in countries with lower health expenditures, lower baseline life expectancy, and

113 population, Medicare, Medicaid, and private health expenditures may be dramatically lower than if de

114 xamined whether different levels of national health expenditure might explain differences in lymphoid

115 Total national health expenditure might influence population-based lymp

116 Behavioral health expenditures nearly doubled to 40% of US child he

117 achieving good health outcomes, with a total health expenditure of 4.47% of gross domestic product in

118 ries were defined as those with a per capita health expenditure of US$100 or less annually.

119 e defined as those with an annual per capita health expenditure of US$100 or less.

120 despite the several times higher income and health expenditures of the United States.

121 age at diagnosis, gender, and total national health expenditure on the relative excess risk of death

122 States spent an estimated 4.5% of its total health expenditures on biomedical research and 0.1% on h

123 following outcomes: health care utilization, health expenditure, or health outcomes.

124 low-income countries in unadjusted analyses: health expenditure (p=0.0002), UHC Index (p<0.0001), ded

125 r drugs (P=0.001) without increasing overall health expenditures (P=NS).

126 or 174 countries, we projected country-level health expenditure per capita and life expectancy increa

127 Population and health expenditure per capita data were obtained from th

128 Population and annual health expenditure per capita data were obtained from th

129 ions on the evolution of life expectancy and health expenditure per capita is set within predefined g

130 Countries with high health expenditure per capita tended to have better care

131 Doubling in decadal health expenditure per capita was associated with ~ 7% i

132 e available, the rate was imputed from total health expenditure per capita, fertility rate, life expe

133 P < .001), respectively (adjusted for total health expenditure per capita, population, percent of ur

134 egression was used to estimate excess annual health expenditure per person.

135 ost-effectiveness thresholds on the basis of health expenditures per capita and life expectancy at bi

136 ss ratio will affect the rate of increase of health expenditures per capita and life expectancy at th

137 t of physical multimorbidity on catastrophic health expenditures persisted even among the higher soci

138 d for economic output, adult HIV prevalence, health expenditure, population density, the percentage o

139 ficant after individual adjustment for total health expenditure, public expenditure on health, health

140 ified according to their mean total national health expenditure quartile in 2001-13.

141 lower) in countries in the highest national health expenditure quartile than in countries in the low

142 V-2 infection among HCWs as a share of total health expenditure ranged from 1.51% in Colombia to 8.38

143 The benefit in reduced health expenditures resulted in savings of 3.81 US dolla

144 t increase in administration's share of U.S. health expenditures since 1999, 2.4 percentage points wa

145 r insurance change or loss) and catastrophic health expenditures (spending >10% income) were calculat

146 or income inequality, and the share of total health expenditure spent by social security funds, other

147 iseases simultaneously generally had greater health expenditure than the expected sum of having the d

148 Increasing the share of total health expenditure that is prepaid, especially through t

149 is required is increasing the share of total health expenditure that is prepaid, particularly through

150 A ten point increase in the percentage of health expenditures that were out-of-pocket was associat

151 attern of disbursements in relation to total health expenditure (THE), government health expenditure

152 These health system characteristics include health expenditure, the Universal Health Coverage Servic

153 protection by the incidence of catastrophic health expenditures (those exceeding 10% of household co

154 will need to invest about 9.0% of its yearly health expenditure to enable sufficient scale up in scre

155 treatment care and further justify increased health expenditures to prevent RR-TB transmission.

156 Policies on expanding health expenditures to promote appropriate use of antibi

157 munization coverage scenarios, out-of-pocket health expenditures, transportation costs, wage losses,

158 99, administration accounted for 31% of U.S. health expenditures versus 16.7% in Canada.

159 nting to $2497 per capita (34.2% of national health expenditures) versus $551 per capita (17.0%) in C

160 as measured by the cumulative percentage of health expenditure vs percentage of ranked population.

161 At the population level, 23.8% of total health expenditure was attributable to higher costs of h

162 A majority (59%) of health expenditure was attributable to NCDs.

163 the 20th to 80th percentile of out-of-pocket health expenditures was associated with an increase in r

164 rcent of gross domestic product and national health expenditure, was reported from an LIC.

165 ion, country income level, and out-of-pocket health expenditure were significantly associated with ca

166 lds of 25% and 40%, as well as impoverishing health expenditures were estimated.

167 Significantly lower health expenditures were noted with favorable CRF profil

168 Out-of-pocket health expenditures were strongly correlated with antimi

169 Out-of-pocket health expenditures were the only factor significantly a

170 Finally, we find that greater health expenditure will improve population health outcom

171 It has a major impact on public health expenditures with more than 1 in 10 health care d

172 ath and disability, and account for 90.2% of health expenditure worldwide.